Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12624001124527Phase 4Completed
Phase 4, randomised, open-label trial in general anesthesia comparing Remimazolam group with Propofol group (2 arms). Primary endpoints: Anesthesia depth determined by BIS score and Anesthesia depth determined by PSI score. Started Sep 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12624001124527.